Global CEUS and available agents

Click on any country to see the agent(s) marketed in that country.

[show-map id=”1″ controls=’top-left’]

Additional availability —  Hong Kong (SonoVue, Bracco Diagnostics); Singapore (Definity, Lantheus Medical Imaging; SonoVue, Bracco Diagnostics).

* See package inserts for approved indications.   This map will be updated from time to time as new information is received.  The International Contrast Ultrasound Society (ICUS) does not warrant the accuracy of information provided or the suitability of any drug or other medical product for use in individual patients, nor does ICUS provide medical advice.  Medical decisions are the responsibility of health care providers and their patients, who are encouraged to carefully examine and balance the potential risks and benefits associated with the use of any medical procedure including contrast enhanced ultrasound (CEUS), as well as the drugs and other medical products associated therewith.